These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 289325)

  • 1. Muscle breakdown and lysosomal activation (biochemistry).
    Pearson CM; Kar NC
    Ann N Y Acad Sci; 1979; 317():465-77. PubMed ID: 289325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Muscular dystrophy and activation of proteinases.
    Kar NC; Pearson CM
    Muscle Nerve; 1978; 1(4):308-13. PubMed ID: 35747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dipeptidyl peptidases in human muscle disease.
    Kar NC; Pearson CM
    Clin Chim Acta; 1978 Jan; 82(1-2):185-92. PubMed ID: 618680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Demonstration of cathepsins B, H and L in xenografts of normal and Duchenne-muscular-dystrophy muscles transplanted into nude mice.
    Takeda A; Jimi T; Wakayama Y; Misugi N; Miyake S; Kumagai T
    Biochem J; 1992 Dec; 288 ( Pt 2)(Pt 2):643-8. PubMed ID: 1463465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of the intramyofibral autophagic-lysosomal system in muscular dystrophy.
    Kominami E; Kunio I; Katunuma N
    Am J Pathol; 1987 Jun; 127(3):461-6. PubMed ID: 3296770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abnormal expression of lysosomal cysteine proteinases in muscle wasting diseases.
    Katunuma N; Kominami E
    Rev Physiol Biochem Pharmacol; 1987; 108():1-20. PubMed ID: 3306875
    [No Abstract]   [Full Text] [Related]  

  • 7. Lysosomal and nonlysosomal hydrolases of skeletal muscle in neuromuscular diseases.
    Takala TE; Myllylä VV; Salminen A; Tolonen U; Hassinen IE; Vihko V
    Arch Neurol; 1983 Sep; 40(9):541-4. PubMed ID: 6351816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activity of some proteolytic enzymes in normal and dystrophic human muscle.
    Kar NC; Pearson CM
    Clin Biochem; 1979 Apr; 12(2):37-9. PubMed ID: 36240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phosphomannosyl receptors of lysosomal enzymes of skeletal muscle in neuromuscular diseases.
    Salminen A; Marjomäki V; Tolonen U; Myllylä VV
    Acta Neurol Scand; 1988 Jun; 77(6):461-7. PubMed ID: 2841820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methylthioadenosine nucleosidase in normal and dystrophic human muscle.
    Kar NC; Pearson CM
    Clin Chim Acta; 1980 Dec; 108(3):465-8. PubMed ID: 6781797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification and possible regulation of muscle cell lysosomal protease activity by exogenous protease inhibitors.
    Stauber WT; Gauthier F; Ong SH
    Acta Biol Med Ger; 1981; 40(10-11):1317-22. PubMed ID: 7043996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coordinate activation of lysosomal, Ca 2+-activated and ATP-ubiquitin-dependent proteinases in the unweighted rat soleus muscle.
    Taillandier D; Aurousseau E; Meynial-Denis D; Bechet D; Ferrara M; Cottin P; Ducastaing A; Bigard X; Guezennec CY; Schmid HP
    Biochem J; 1996 May; 316 ( Pt 1)(Pt 1):65-72. PubMed ID: 8645234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The metabolism of cyclic-3'-5'-adenosine monophosphate (cAMP) in diseased muscle.
    Canal N; Frattola L; Smirne S
    J Neurol; 1975; 208(4):259-65. PubMed ID: 50411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early elevation of cathepsin B1 in human muscle disease.
    Kar NC; Pearson CM
    Biochem Med; 1977 Aug; 18(1):126-9. PubMed ID: 901428
    [No Abstract]   [Full Text] [Related]  

  • 15. Increases in cathepsins B and L and thiol proteinase inhibitor in muscle of dystrophic hamsters. Their localization in invading phagocytes.
    Kominami E; Bando Y; Ii K; Hizawa K; Katunuma N
    J Biochem; 1984 Dec; 96(6):1841-8. PubMed ID: 6530400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Arylamidase and cathepsin-A activity of normal and dystrophic human muscle.
    Kar NC; Pearson CM
    Proc Soc Exp Biol Med; 1976 Mar; 151(3):583-6. PubMed ID: 3799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased structure-linked latency of lysosomal dipeptidyl aminopeptidase-I activity in Duchenne muscular dystrophy fibroblasts.
    Davis MH; Gelman BB; Gruenstein E
    Neurology; 1982 May; 32(5):486-91. PubMed ID: 7200205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased endocytosis with lysosomal activation in skeletal muscle of dystrophic mouse.
    Libelius R; Jirmanova I; Lundquist I; Thesleff S
    J Neuropathol Exp Neurol; 1978; 37(4):387-400. PubMed ID: 681982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunocytochemical studies of cathepsin D in human skeletal muscle.
    Whitaker JN; Bertorini TE; Mendell JR
    Ann Neurol; 1983 Feb; 13(2):133-42. PubMed ID: 6338808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Skeletal muscle lysosomes: comparison of lysosomes from normal and dystrophic avian pectoralis muscle as a function of age.
    Baxter JH; Suelter CH
    Muscle Nerve; 1983; 6(3):187-94. PubMed ID: 6855805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.